Statistiche web
October 10, 2024

bio

IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide

IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide

AETOSWire November 21, 2023
NANJING, China — Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the 6th China International...
Read More Read more about IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide
Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform Auto Draft

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

AETOSWire January 25, 2023
WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety...
Read More Read more about Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform
Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

AETOSWire December 6, 2022
WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...
Read More Read more about Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis
Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

AETOSWire November 24, 2022
WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...
Read More Read more about Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

You may have missed

Global Green Industry Leaders Unite at Eco Expo Asia 2024

Global Green Industry Leaders Unite at Eco Expo Asia 2024

October 10, 2024
Danube Home sets up the largest home interior & outdoor solutions showroom in Musaffah Abu Dhabi Danube Home sets up the largest home interior & outdoor solutions showroom in Musaffah Abu Dhabi

Danube Home sets up the largest home interior & outdoor solutions showroom in Musaffah Abu Dhabi

October 10, 2024
12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders 12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders

12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders

October 10, 2024
12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders 12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders

12th Annual GOV HR and Youth Summit and Awards Receives a Thumping Response from the Industry Stakeholders

October 10, 2024
free web counter